Introduction
Even well-intended diagnostic purchases can under-deliver when they clash with day-to-day clinical realities—think inconsistent results, stalled workflows, or reimbursement headaches. Drawing on our support and field implementation experience, HealthWright Technologies Inc has identified five pitfalls that routinely reduce clinical effectiveness. Here’s how the CMAT Advantage—our flagship CMAT device for PAD, autonomic-nerve, and sudomotor testing—solves each one.
Pitfall 1 | Operator-Dependent Variability
The problem
Handheld Doppler ABI or single-probe devices hinge on precise probe placement, angle, and cuff inflation. Skill gaps create inconsistent results and repeat studies.
CMAT Advantage fix
- Automated cuffs & sensors remove probe-angle guesswork.
- Dual-channel plethysmography self-calibrates; no manual waveform tracing.
- 60-minute MA e-learning certifies staff quickly and uniformly.
Outcome: Consistent, reproducible data regardless of who runs the test.
Pitfall 2 | Single-Parameter Blind Spots
The problem
Devices that measure only ABI (or a surrogate index) can miss PAD in diabetics with calcified vessels and reveal nothing about autonomic or small-fiber neuropathy.
CMAT Advantage fix
- Multi-modal testing (ABI + PVR + ANS HRV + sudomotor) captures vascular and neuropathic risk in one 7 to 10 minute pass.
- Color-coded reports flag borderline findings that single-parameter tools overlook.
Outcome: Broader diagnostic coverage across three CPT domains—not just PAD.
Pitfall 3 | Workflow Bottlenecks & Patient Throughput
The problem
Manual ABI takes 12 to 20 minutes and ties up an RN or sonographer, disrupting clinic flow.
CMAT Advantage fix
- Simultaneous arm/ankle cuffs and automated cycling cut chair time to ≈ 7 minutes.
- PDF report downloads at the point of care for the practitioner to sign and upload to the patient’s chart.
- Self-test diagnostics avoid mid-clinic maintenance surprises.
Outcome: Adds < 3 minutes beyond routine vitals, even during peak hours. Our step-by-step guide to streamlining non-invasive cardiovascular diagnostics shows the full check-in to signed-chart workflow.
Pitfall 4 | Reimbursement & Audit Exposure
The problem
Newer “ABI-surrogate” technologies face payer scrutiny; incorrect coding or weak documentation can trigger denials or claw-backs.
CMAT Advantage fix
- Uses established CPTs 93923, 95921, 95923—no experimental surrogates.
- Includes an informational CPT code reference guide. Correct coding is the responsibility of the billing provider.
Outcome: Cleaner first-pass claims and reduced audit risk.
Pitfall 5 | Hidden Lifecycle Costs
The problem
Low entry prices often mask pricey disposables, annual license fees, or mandatory service contracts.
CMAT Advantage fix
- Flat-rate consumables with volume discounts; no proprietary probes.
- Secure software-update downloads included—no tiered “premium” unlocks.
- Warranty service covers replacement of a defective CMAT Advantage device within a set number of business days of your notice, plus technical support by internet Monday through Friday, Eastern time. The exact replacement window and support hours are set out in the purchase agreement. If a unit needs repair, loaned equipment may be provided under a Return Merchandise Authorization (RMA).
Outcome: Transparent total cost of ownership and faster transparent pricing with no hidden fees.
Key Takeaways for Physicians
- Consistency: Automation neutralizes operator variability.
- Completeness: Multi-parameter testing uncovers vascular and neuropathic disease.
- Efficiency: 7 to 10 minute workflows preserve clinic capacity.
- Compliance: Established CPTs and audit-ready docs support proper billing practices.
Economics: Predictable operating costs and transparent pricing.
Ready to get started? Learn how HealthWright Advantage bundles the device, training, and ongoing support your practice needs — backed by our 60-day buyback: bill the CMAT Advantage tests correctly and compliantly, and if Medicare does not reimburse them, we buy the system back.
Questions about how these pitfalls apply to your practice? Book a 25-minute demo, contact HealthWright Technologies, or call (678) 322-7146 and we will follow up.
Frequently Asked Questions
What should independent physicians evaluate before buying a PAD or vascular diagnostic device?
Prioritize four things: result consistency, the number of clinically useful parameters captured per test, real-world chair time, and total cost of ownership. Operator-dependent handheld devices and single-parameter tools are the most common sources of repeat studies and missed disease. A multi-parameter platform such as the CMAT Advantage system measures ABI, PVR, autonomic HRV, and sudomotor function in a single pass, which reduces both diagnostic blind spots and rework. For a side-by-side breakdown, see CMAT Advantage vs. traditional PAD testing devices.
That evaluation framework is also why many independent practices are moving diagnostic testing in-house; see why non-invasive cardiovascular diagnostics are the future of primary care.
How long does a CMAT Advantage test take to run?
A complete CMAT Advantage test typically takes about 7 to 10 minutes of patient chair time. Automated, simultaneous arm and ankle cuffs cycle without manual probe placement, so the multi-parameter test adds fewer than 3 minutes beyond routine vitals even during peak clinic hours. By comparison, manual ankle-brachial index testing can take 12 to 20 minutes and occupy a nurse or sonographer — see what an ABI test involves.
Which CPT codes does the CMAT Advantage support?
The CMAT Advantage maps to established CPT codes 93923 (extremity arterial studies), 95921, and 95923 (autonomic nervous system function testing), rather than experimental ABI-surrogate codes. Using recognized codes supports cleaner first-pass claims and reduces audit exposure. Correct coding and documentation remain the responsibility of the billing provider; the system includes an informational CPT reference guide to assist. Learn how these stack in three CPT codes from one CMAT device visit.
Is the CMAT Advantage FDA-cleared?
Yes. The underlying device is FDA-cleared under the 510(k) pathway for its labeled non-invasive testing functions. The correct regulatory term for a 510(k) diagnostic device is “FDA-cleared,” not “FDA-approved.” Detailed regulatory documentation is available on the FDA 510(k) device information page.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis, treatment, and clinical decision-making.
CPT codes are provided for informational purposes only and do not guarantee reimbursement. Verify code applicability and coverage with the relevant payer and your billing department before submitting claims. CPT® is a registered trademark of the American Medical Association.
Ready to see the CMAT Advantage in your practice?
Book a free 25-minute demo: see the full PAD + autonomic workup and how the three established CPT codes apply, with no obligation. Backed by our 60-day buyback guarantee.
Book a Free Demo →
